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ABSTRACT 
Phytochemical screening of chloroform and methanolic extracts of different parts of Solanum torvum and Smilax zeylanica was done. In vitro 
thrombolytic and anti-arthritic activities were assessed using the clot lysis method and egg albumin denaturation technique respectively. 
Between the chloroform and methanolic extracts, Chloroform extracts of both plants showed higher clot lysis activities (at 10 0 ppm solution). 
On the other hand, extracts of both plants performed better in terms of anti-arthritic activities (at 500 ppm solution). In the case of 
thrombolytic activity, between the plant extracts, the performance of S. torvum is higher compared to S. zeylanica plant. Among chloroform 
extracts of different plant parts, stem of S. torvum and root of S. zeylanica showed the highest, 35.44±1.89 % and 33.63±0.83 % activities 
respectively. Whereas, among the methanolic extracts of the plants, the root extracts of both plants showed the highest activ ities, 31.96±2.86 % 
for S. torvum and 32.01±1.46 % for S. zeylanica. In the case of anti-arthritic activity, the performance of S. zeylanica plant extracts is higher 
compared to that of S. torvum. Methanolic extract of leaf of S. zeylanica samples showed the best protein denaturation activity (52.38±2.12 %) 
followed by the Methanolic extract of stem sample of S. torvum  (44.29±2.14 %).  
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INTRODUCTION: 
Thrombosis (Blood clot) is a severe medical condition. In this 
condition, blood clots are formed usually in veins in the 
pelvis, thigh, lower leg, and sometimes in arms. Recovering 
from this leads illness, disability and even death.1 This is the 
leading global cause of death because of cardiovascular 
disease (more than 17.9 million deaths in 2015) and the rate 
of death by this disease is expected to raise upto more than 
23.6 million by 2030 per year.2 Thrombolytic agents, that are 
commonality all around the world, are tissue plasminogen 
activator, streptokinase, urokinase, anti-streptokinase etc. 
These agents function by dissolve clots.3 Till now 
thrombolytic agents suffer from complications related to 
bleeding, including the large quantity needed for being 
maximally effective, relative fibrin specificity and risk of 
hemorrhage.4 Due to adverse effects of thrombolytic drugs, 
researches are in progress to design new and improved 
treatment and some of them have already been developed 
but safety is yet a key concern.5 Significant efforts have been 
taken to discover and develop natural constituents from 
various animal and plant sources having thrombolytic, 
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antithrombotic, antiplatelet and anticoagulant activities.6. 
These studies and investigations in this area will open new 
horizon to encourage the advancement of the ultimate 
alternative thrombolytic therapy.6 
Arthritis, an autoimmune disease, is another ubiquitous 
disease all over the world which is characterized by the 
association of pain, stiffness and swelling. It is caused by 
inflammation of the synovial joint as a consequence of 
immune mediated response. One fifth of the world’s elderly 
suffer from arthritis.7 Several drugs are used for arthritic 
treatment like NSAIDs, glucocorticoids, methotrexate, 
sulfasalazine, D-penicillamine, infliximab, etanercept, 
anakinra, abatacept, cyclosporine, azathioprine, and 
cyclophosphamide etc..8–10 These therapeutic agents function 
by reducing the inflammation and joint destruction. Mainly, 
anti-arthritic activity means to hinder denaturation of 
protein and control the production of auto-antigen and 
membrane lysis in rheumatic disease.11, 12 However, 
prolonged use of these drugs onsets several risks including 
cardiovascular intricacies, gastrointestinal ulcers, 
hematologic and pulmonary toxicities, nephrotoxicity, 
myelosuppression, stomatitis, hepatic fibrosis, diarrhoea, 
cirrhosis, immune and local injection-site reactions. 
Furthermore, high expense and side effects comprising 
malignancies and high risks of infections requires the need 
for continuous monitoring.13 In contrast to the conventional 
medicines, Arthritic conditions if treated using traditional 
medicines, bring about considerable success causing no side 
effects. So there is an urge to develop new therapeutic agents 
with minimum side effects. 
Herbal medicines are in use for treating various ailments 
since time immemorial.14 They are formulated from the 
therapeutic expertise of generation of practicing physicians 
of centuries old ancient.15 Medicinal plants are the blessings 
of nature which are widely distributed source of therapeutic 
agents for the preventive and curative measures of various 
diseases.16  
Solanum torvum is an erect or spreading prickly shrub which 
is often used in traditional medicine for controlling diabetes 
and strengthening the bones, preventing gas trouble and 
teeth related diseases, curing paralysis. Extracts of different 
parts of this plant is very useful the treatment of waist 
stiffness, sick stomach, swelling beaten, heart pounding, no 
menstruation, eye and vision problems etc..17, 18 Fruit and 
fruit coat of this plant possesses antifungal, antibacterial, 
antioxidant, antidiabetic, anthelmintic, immuno modulatory 
and erythropoietic, hepatoprotective, angiotensin-converting 
enzyme (ACE) inhibitory properties, cardiovascular and anti-
platelet aggregation activities due to the presence of quality 
amount of phenols and flavonoids, isolated methyl caffeate.19, 
20, 21–28, 29–35 An isoflavonoid ‘Torvanol A’ was isolated from 
the seed of S. torvum which have antidepressant, anxiolytic 
and adaptogenic activities.36 Methanolic and aqueous 
extracts of this plant show significant antiulcerogenic activity 
as well.37 Spirostanol glycosides and steroidal lactone 
saponins prevailing in ethanolic extracts of the aerial parts of 
this plant have been proven to be responsible for cytotoxic 
effect.17 
Smilax zeylanica L. is a climbing shrub with prickly stem, 
locally known as Kumarilata, has been used for the treatment 
of various minor and major ailments from ancient time. In 
tradition medicine, roots and leaves of S. zeylanica are used 
as a substitute for sarsaparilla, for the treatment of venereal 
diseases, eczema, abscess; the decoction is used for pain in 
the lower extremities, rheumatism, skin diseases, sores 
swellings, gonorrhea, gout, syphilis, blood purifier, and also 
used for dysentery controlling.38 Alcohol and aqueous 
extracts of roots and rhizomes of S. zeylanica have been 
found potential for antiepileptic, hepato-protective 
activities.38, 39 In vitro and vivo pharmacological activities of 
the extracts from the plant's different parts are attributed to 
the presence of Glycosides, Diosgenin, β-Sitosterol, 
Polyphenolic compounds and tannins, Saponins, 
Sarsasapogenin/ Smilagenin.40-42 These compounds also 
bestow the plant extracts with antimicrobial, antidiabetic 
activity, anticonvulsant, anthelmintic properties as well as 
analgesic activities.43–47 
Since there is no scientific report on thrombolytic and anti-
arthritic potential of Solanum torvum and Smilax zeylanica 
extracts, in the present study evaluation of the thrombolytic 
and anti-arthritic effect of these plant extracts were assessed 
in vitro. 
MATERIALS AND METHODS: 
Preparation of extract  
The plants (Solanum torvum & Smilax zeylanica) were 
collected from Savar, Dhaka and authentications were done 
by Bangladesh National Herbarium, Dhaka. Identification was 
completed previously by Prof. A.T.M. Nadiruzzaman, 
Department of Botany, University of Rajshahi, Rajshahi, 
Bangladesh. Different parts of Plants (in case of S. torvum, the 
experimented parts were leaf, stem, root & inflorescence and 
in case of S. zeylanica, the experimented parts were leaf, stem 
& root) were washed with ethanol and dried separately at 
room temperature (22 ± 0.5 °C) for 15 days and grounded 
into powder. Soxhelt’s apparatus was used to get the extracts. 
In a soxhlet apparatus approximately 250 gm of each plant 
part were soaked for 7 days both in 1.0 L of chloroform 
(CHCl3) and methanol (CH3OH). Filtrates were obtained 
through Buchner funnel by filter paper No. 11 (whatman) 
and concentrated those by a rotary evaporator operating 
below 40°C. 10 mg of individual extract was suspended in 10 
ml distilled water and vortexed vigorously by vortex mixer. 
In this manner, both methanolic and chloroform extracts of 
100 ppm concentration were prepared for assessing the 
thrombolytic properties and the concentrations (66.5, 125, 
250, 500 ppm) of both methanolic and chloroform extracts 
were prepared for screening for their antiarthritic activity.   
Phytochemical screening 
The phytochemical analysis of S. torvum & S. zeylanica was 
done through standard procedures as narrated in Trease & 
Evans (2009); Harbone (1998) and Tona (1998). Specifically, 
the extracts were assessed for the presence of secondary 
metabolites (saponins, glycosides, steroids, alkaloids, 
flavonoids, phenols, tannins & terpenoids) and 
macronutrients (carbohydrates & proteins).48–50 
Test for Alkaloids:  
For this test, an amount of 0.2 gm extracts were boiled on a 
steam bath with 2% HCl (5 ml). The solutions were then 
filtered and 1 ml of the filtrates was taken in separate test 
tubes. Filtrates in individual test tubes were then treated 
with 2 drops of the mayer’s reagent (potassium mercury 
iodide solution). A precipitate of creamy white colour proves 
the presence of alkaloids. 
Test for Flavonoids 
An amount of 0.2 gm extracts were heated with ethyl acetate 
(10 ml) for 3 minutes in water bath at 100 °C. The solutions 
were filtered and filtrates were kept for the following tests: 
(1) Ammonium test: Each of the filtrates (4 ml) was shaken 
vigorously with 1% dilute ammonia solution (1 ml). The 
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layers were allowed to separate. Presence of flavonoids 
confirms when yellow color forms at ammonia layer. 
(2) Aluminum chloride test: Each of the filtrates (4 ml) was 
shaken vigorously with 1% aluminum chloride (1 ml) and 
determined for yellow color formation. Presence of 
flavonoids confirms when yellow precipitate forms. 
Test for Glycosides 
Keller-killiani test: A quantity (0.5 g) each of the extracts was 
once dissolved in 2ml of chloroform and filtered them. Then 
the filtrates were accrued in test tubes and evaporated to 
dryness. After that of glacial acetic acid (1 ml) and three 
drops of 5% w/v ferric chloride added. Afterwards 1 ml of 
focused sulphuric acid delivered cautiously via the aspect of 
the take a look at tube. The development of bluish green 
colour in higher layer suggests the presence of cardiac 
glycosides. 
Test for Steroids 
A volume (0.2 g) every of the extracts used to be dissolved in 
2ml of chloroform. Then the following take a look at had been 
done. 
(1) Salkowski test: Fuming sulphuric acid (2 ml) was once 
brought from the facet of the take a look at tube. The take a 
look at tube was once shaken for a few minutes. The 
development of red coloration in the chloroform layer 
indicates the presence of steroids. 
(2) Liebermann-burchard test: Acetic anhydride (10 
drops) was mixed properly with chloroform Then 2 ml of 
targeted sulphuric acid were added from the facet of the take 
a look at tube. The greenish transient coloration suggests the 
presence of steroids. 
Test for Terpenoids 
A quantity (0.2 g) each of the extracts was dissolved in 2ml of 
chloroform and evaporated to dryness. 2ml of conc. sulphuric 
acid used to be then added and heated for about 2 minutes. 
The presence of terpenoids confirms by development of 
grayish color.  
Test for Saponins 
Froth Test: Extracts (0.1g) had been diluted with distilled 
water to 15 ml and these were shaken in a graduated cylinder 
for 15 minutes. The presence of saponins confirms by 
formation of 1 cm layer of foam.  
Test for Phenols 
FeCl3 Test: An extent (2 g) of the extracts had been boiled 
with 5 ml of 45 % ethanol for 5 min. The combination was 
cooled and filtered. The filtrate was subjected to the Ferric 
chloride test. An extent (1 ml) of the filtrate was diluted with 
distilled water and delivered 3 drops of 5% FeCl3 (w/v). A 
transient greenish to black coloration shows the presence of 
phenols. 
Test of Tannins 
To the 0.2 g of extracts, 1% gelatin (3 ml) containing 10% 
NaCl (few drops) was added. White precipitate confirms the 
presence of tannins. 
Test for Carbohydrates 
An amount of 0.1 g of extracts was shaken with water 
vigorously and filtered. 5 drops of Molisch reagent (alpha-
naphthol dissolved in ethanol) was added to aqueous filtrate 
and shaken vigorously. 1 ml of fuming sulphuric acid was 
added carefully. It was done to form a layer below the 
aqueous solution. The presence of carbohydrate proves by a 
brown ring at the interface. 
Test for Proteins 
(1) Biuret’s Test:To 3 ml of extracts, 1 ml of 4% w/v sodium 
hydroxide and 1ml of 1% w/v copper sulphate had been 
added. The exchange in color of the answer to violet or pink 
indicates the presence of proteins. 
(2) Xanthoprotein Test: To 3 ml of extracts, 1ml of 
concentrated sulphuric acid was added. The look of white 
precipitate which flip to yellow on boiling and orange on 
addition of ammonium hydroxide (1ml) suggests the 
presence of proteins containing tyrosine tryptophan. 
In vitro Thrombolytic analysis 
The thrombolytic recreation of S. torvum & S. zeylanica have 
been performed through following the approach of using 
streptokinase (SK) as a popular reference.51, 52 
Preparation of Standard solution 
Commercially available lyophilized Streptokinase vial of 15 
zero I.U., 5 ml sterilized distilled water was mixed properly. 
This suspension was used as a stock from which a hundred μl 
(30,000 I.U) used to be used as Standard for in vitro 
thrombolysis. All chemical substances in this investigation 
were of analytical reagent grade. 
Blood Collection 
Whole blood (60 ml) was drawn from healthy human 
volunteers (n=15) by phlebotomist besides a history of oral 
contraceptive or anticoagulant therapy. 1ml of blood was 
transferred to each of the sixty before weighed falcon tubes 
to form clots. 
Procedure 
Drawn Blood was giver 15 minutes to form clots. Then the 
falcon tubes loaded with blood were centrifuged at 2000 rpm 
for 1 minute using centrifuge machine (Model: Remi- R-83 A). 
After that, blood serum was completely separated carefully 
without disturbing the blood clot and those falcon tubes were 
reweighted to measure clot weight. Each falcon tube 
containing clot was labeled correctly and 100 µl of different 
plant extracts were added to the falcon tubes. Positive control 
and negative control were used respectively 100 µl of SK & 
100 µl of heparin of one of a kind concentration and 100 µl of 
distilled water. All falcon tubes were then kept in incubated 
at 37°C for 90 minutes to monitor the clot lysis. After 90 
minutes of incubation, dissolved clot was removed and 
differences in weight of the falcon tubes after clot disruption 
were recorded by gravimetric method. The differences in 
weight were calculated as percentage of clot lysis. Each test 
was done in triplicate. 
       % of clot lysis = [(W3 - W1)/ (W2 - W1)] × 100 
Where, 
W1 = Weight of the empty falcon tube 
W2 = Clot weight after treatment with pre-weighted falcon 
tube  
W3 = Initial Clot weight with pre-weighted falcon tube 
Each test was done in triplicate. 
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Antiarthritic Activity (Egg Albumin Denaturation 
Method) 
The arthritic recreation of S. torvum and S. zeylanica had 
been carried out by using following the method of using 
Diclofenac Sodium as a preferred reference.53 
Phosphate Buffer Saline pH 6.4 
8 gm of sodium chloride (NaCl), 0.2 gm of potassium chloride 
(KCl), 1.44 g of disodium hydrogen phosphate (Na2HPO4) and 
0.24 gm of potassium dihydrogen phosphate (KH2PO4) were 
dissolved in 800 ml distilled water. The pH was adjusted to 
6.4 using 1N HCl and make up the quantity to one thousand 
ml with distilled water. 
Procedure     
The reaction mixture for anti-arthritic activity assessment (5 
mL) consisted of 0.2 mL of egg albumin drawn from fresh 
hen's egg, 2.8 ml of phosphate-buffered saline (pH 6.4) and 2 
mL of different concentrations of plant extracts (66.5, 125, 
250, 500 ppm). As a control, similar volume of double-
distilled water was served. . As the standard, varying 
concentrations of diclofenac sodium (66.5, 125, 250, 500 
ppm) was used. After that, the mixtures were incubated at 37 
± 2°C in a BOD incubator for 15 minutes and right after that 
the mixture was heated at 70°C for 5 minutes in a water bath. 
After cooling, the absorbance was measured at 660 nm by a 
UV-Vis Spectrophotometer. Phosphate buffer saline was 
served as Blank. The denaturation of protein was calculated 
by using the following formula: 
                                   % inhibition = 100 × [V / VO - 1] 
Where, 
V  = Test Sample Absorbance 
VO = Control Absorbance 
Each test was done in triplicate. 
Statistical Analysis: 
Data are presented as the suggest ± Standard deviation of 
every triplicate test. The analysis was carried out with the aid 
of ANOVA followed by Dunnett’s t-test. Significance was set at 
P < 0.001 and P < 0.05 levels. 
RESULTS & DISCUSSION: 
Preliminary phytochemical screening: 
Medicinal plants are playing a central role in conventional 
medicine. Traditional health practitioners have long been 
using medicinal plants to treat various diseases.54-56 The 
potential activity of the medicinal plants can be attributed to 
the presence of different kinds of pharmacologically active 
phytochemicals. In this experimental study preliminary 
phytochemical screening was done to qualitatively determine 
the active ingredients present in the plant extracts of S. 
torvum and S. zeylanica according to standard procedures. 
Preliminary phytochemical screening revealed the presence 
of flavonoid, tannin and glycosides in both methanolic and 
petroleum ether extracts. Polyphenolic compounds, like 
flavonoids, tannins and phenolic acids, commonly found in 
plants have been reported to have multiple biological 
effects.55, 57, 58 The found phytochemicals are tabulated in the 
following table (Table 1). The positive signs of the 
phytochemicals confirm the presence of saponins, steroids, 
glycosides, terpenoids, carbohydrates, phenols, flavonoids, 
alkaloids and proteins in the plant extracts. However, the 
only phytochemical that is absent in all extracts is tannin 
(Table 1). 
  
Table 1. Presence of different phytochemicals in two fractions (methanol & chloroform) of different parts of Solanum torvum 
and Smilax zeylanica. 
Sample Name Chemical Group Test 
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Smt/Leaf/MeOH + + + + + + ++ - + - 
Smt/Leaf/CHCl3 + + + - + + - - + ++ 
Smt/Stem/MeOH - + + + + + + - + ++ 
Smt/Stem/CHCl3 - + - - + + - - + ++ 
Smt/Root/MeOH - - - + + + - - + ++ 
Smt/Root/CHCl3 - + + + + + - - + + 
Smt/Inflorescence/MeOH + + + + + + + - + ++ 
Smt/Inflorescence/CHCl3 - + + + + + - - - ++ 
Sxz/leaf/MeOH - + + + + + ++ - + + 
Sxz/leaf/CHCl3 - + + + + + - - + ++ 
Sxz/Stem/MeOH - + + + + + ++ - + ++ 
Sxz/Stem/CHCl3 - - - - + + - - - ++ 
Sxz/Root/MeOH - - + + + + - - - ++ 
Sxz/Root/CHCl3 - - + - + + - - - + 
NB: Smt indicates Solanum torvum, Szx indicates Smilax zeylanica and (+) indicates presence, (-) indicates absence 
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In vitro thrombolytic activity 
The clot lysis percentage results of the methanolic and 
chloroform extracts of different parts of S. torvum, positive 
control (streptokinase) and negative control (water) are 
shown in Figure 1. For positive control (100 μL of 
streptokinase (30,000 IU), the clot lysis was found to be 
76.15 ± 1.94 %, while in the case of negative control (water) a 
very negligible amount of clot lysis (3.59 ± 0.46%) was found.  
It can be seen from the figure (Figure-1) that, S. torvum 
induced in vitro clot lysis 35.44 ± 1.89 %, 28.67 ± 2.59%, 25.9 
± 1.01 % & 20.51±2.83 % for 100 ppm concentration of 
chloroform (CHCl3) extracts of stem, leaf, root & inflorescence 
samples and 31.96 ± 2.86 %, 31.0 ± 2.1 %, 22.05 ± 4.48 % & 
21.82 ± 1.29 % for 100 ppm concentration of methanolic 
(CH3OH) extracts of root, stem, inflorescence and leaf 
samples respectively. 
 
 
Figure 1. Thrombolytic properties of methanolic & Chloroform extracts of different parts of Solanum torvum compared with 
Standard (Streptokinase). 
 
Figure 2 summarizes the clot lysis results by chloroform 
and methanolic extracts of different parts of S. zeylanica in 
percentage, positive control (streptokinase) and water as 
negative control. Clot lysis was 76.15 ± 1.94 % for the 
positive control (100 μL of 30,000 IU streptokinase). 
Compared to the positive control, the negative control 
(water) showed very negligible clot lysis (3.59 ± 0.46%).  
It is shown in Figure 2 that S. zeylanica induced in vitro clot 
lysis 33.63 ± 0.83%, 31.61 ± 2.31 % & 17.19 ± 1.65 % for 
100 ppm concentration of chloroform (CHCl3) extracts of 
root, stem & leaf samples and 32.01 ± 1.46 %, 22.02 ± 
1.70% and 15.02 ± 0.38 % for 100 ppm concentration of 
methanolic (CH3OH) extracts of root, stem and leaf samples 
respectively. 
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Figure 2. Thrombolytic properties of methanolic and Chloroform extracts of different parts of Smilax zeylanica compared with 
Standard (Streptokinase). 
 
In vitro anti-arthritic activity: 
The denaturations of proteins along with the membrane 
lysis action are held responsible for the production of auto 
antigens in certain arthritic diseases. Different plant 
extracts of different parts were subjected to monitor their 
anti arthritic activities in vitro. The results are shown in the 
following figures (Figure 3 and Figure 4). Figure 3 
represents the data of antiarthritic activity of S. torvum 
plant extracts. For the plant  The maximum protein 
denaturation inhibition percentage was observed for 
methanolic (CH3OH) extracts of stem, leaf, inflorescence & 
root samples are 44.29 ± 2.14, 42.54 ± 0.49, 39.29 ± 0.71 & 
21.14 ± 2.09 and chloroform (CHCl3) extracts of root, leaf, 
stem & inflorescence samples are 35.15 ± 1.58, 33.85 ± 
2.03, 33.28 ± 1.31 & 23.47 ± 1.07 at 500 ppm respectively 
for S. torvum. Whereas standard (diclofenac sodium) shown 
85.10 ± 0.45 at same ppm (Fig. 3). The minimum inhibition 
percentage was observed in case of methanolic (CH3OH) 
extracts of leaf, stem, inflorescence & root samples 
are15.52 ± 0.93, 10.07 ± 0.67, 9.27 ± 0.94 & 4.29 ± 0.62 and 
chloroform (CHCl3) extracts of root, leaf, stem & 
inflorescence samples are16.29 ± 1.62, 10.29 ± 1.27, 8.71 ± 
1.16 & 7.57 ± 0.89 at 66.5 ppm respectively for S. torvum. 
whereas standard (diclofenac sodium) shown 45.51 ± 1.21 
% at the same ppm (Fig. 3). 
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Figure 3. Antiarthritic activity of methanolic (CH3OH) & chloroform (CHCl3) extract of different parts of Solanum torvum 
compared with Standard (Diclofenac Sodium) 
 
The maximum anti-arthritic activity was observed in 
methanolic (CH3OH) extracts of leaf, stem & root samples 
are 52.38 ± 2.12, 32.24 ± 1.45 & 24.71 ± 1.76 and 
chloroform (CHCl3) extracts of stem, root & leaf samples are 
34.92 ± 1.28, 33.02 ± 0.81 & 30.32 ± 0.66 at 500 ppm 
respectively for S. zeylanica. Whereas standard (diclofenac 
sodium) showed an activity of 85.10 ± 0.45 at the same 
ppm (Fig. 4). The minimum was observed in methanolic 
(CH3OH) extracts of leaf,stem & root samples are 25.24 ± 
0.53, 9.45 ± 0.98 & 5.23 ± 0.51 and chloroform (CHCl3) 
extracts of root, stem & leaf samples are 14.65 ± 1.53, 11.57 
± 1.25 & 8.73 ± 0.85 at 66.5 ppm respectively for S. 
zeylanica. Whereas standard (diclofenac sodium) showed 
45.51 ± 1.21 at same ppm (Fig. 4). 
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Figure 4. Antiarthritic activity of methanolic & chloroform extracts of different parts of Smilax zeylanica compared with 
Standard (Diclofenac Sodium) 
 
The results of our study reveal that extracts of S. torvum and 
S. zeylanica have proven to be potential candidate in clot 
lysis, controlling the production of auto antigens. These 
extracts are also capable of inhibiting protein denaturation 
and membrane lysis in arthritic disease. Our present studies 
suggest that extracts of S. torvum and S. zeylanica exhibit 
moderate to low anti arthritic property but they could be 
potential sources of thrombolytic and anti-arthritic elements. 
Anti-arthritic activity of the extracts of S. torvum and S. 
zeylanica might be due to the presence of active 
phytochemicals such as phenols, alkaloids, terpenoids, 
steroids, flavonoids and glycosides as they are proven to have 
these phytochemicals (Table 1).59 Furthermore, 
phytochemicals such as terpenoids, alkaloids and flavonoids 
are held responsible for the thrombolytic activities of 
extracts of S. torvum and S. zeylanica.60–62  
CONCLUSION:  
Methanolic extracts of different parts of Solanum torvum and 
Smilax zeylanica possess mild to moderate thrombolytic and 
antiarthritic activity. Those may be a probable source of 
thrombolytic and arthritic drugs as a candidate for the future. 
However, in vivo clot lysis and antiarthritic activity and 
corresponding to active components responsible for the 
activity are yet to be found out. Positive results give us hope 
to develop drugs in the future and once found S. torvum and 
S. Zeylanica as a potent thrombolytic and antiarthritic agent, 
those will be incorporated for the improvement of suffering 
of the patients from atherothrombotic and rheumatism 
diseases respectively.  
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